INDIANAPOLIS: The report describes the key fact that the mechanism of action of most current and pipeline therapies for Parkinson’s disease is different. Most current therapies focus on neuromodulatory receptors, whereas a majority of pipeline products act in a neuroprotective fashion, targeting and eliminating dysfunctional Read More »

SAN JOSE: Deep-brain stimulation (DBS) targeting the subthalamic nucleus with a multiple-source constant-current device effectively suppresses motor symptoms in patients with advanced Parkinson’s disease (PD), report researchers.

The 16-output, multiple-channel, constant-current device used in the study allows shaping of the electrical field, which the researchers Read More »

SAN ANTONIO: In patients with Parkinson’s disease, the development of amyloid plaque might be a two-step process — cortical deposits followed by striatal deposits — new research suggests.

“The clinical implication is that the early detection of cortical-only plaques in patients may provide a window Read More »

HOUSTON: A new imaging technique can identify the specific changes in neural communication that can disrupt functional connectivity across the brain as a result of mild traumatic brain injury (mTBI).

This information could help explain why many patients with a diagnosis of mTBI will experience Read More »